Midsona AB (publ) (MSON-B)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 10.35 |
|---|---|
| 52-week range | 7.39 – 15.50 |
| Return, 1 month / 3 months | −1.0% / −14.8% |
| Return, 1 year / 3 years | +32.7% / +54.1% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 41.5% |
| Worst drawdown (1 year) | -32.8% |
| Average daily value traded | 1.18M SEK |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Midsona is a Swedish company that develops and markets health and wellness products under its own brands. Its range covers organic and natural foods, dietary supplements, gluten-free and plant-based items, and personal care goods. The company sells mainly through grocery chains, health food shops and pharmacies in the Nordic countries and other parts of Europe. Midsona is based in Sweden and works with contract manufacturers and its own production sites to supply these branded products to consumers.
The shares are listed on the Stockholm Exchange in Sweden under the code MSON-B, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Midsona AB (publ) (MSON-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 10.35 on 19 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 478 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 32.7% and over the last three months it fell 14.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.1% | ||
| From 52-week high | -31.5% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.8% | ||
| 6-month return | -18.7% | ||
| 12-month return, skipping the last month | 33.9% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.8% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.18M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | −1.0% |
| 3 months | −14.8% |
| 6 months | −18.7% |
| 1 year | +32.7% |
| 3 years | +54.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 10.77 / 11.77 |
|---|---|
| Golden / death cross (60 days) | Death, 20 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | SEK 0.2200 |
| 8 May 2025 | SEK 0.2000 |
| 25 Oct 2021 | SEK 0.6000 |
| 6 May 2021 | SEK 0.6500 |
| 29 Oct 2020 | SEK 0.6000 |
| 26 Jun 2020 | SEK 0.6500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.